为诊断阿尔茨海默氏病和其他神经退化性疾病开发血液检测的藤里比奥和艾赛伙伴。 Fujirebio and Eisai partner to develop blood tests for diagnosing Alzheimer's and other neurodegenerative diseases.

Fujirebio和Eisai已同意合作研究和开发用于诊断包括阿尔茨海默氏病在内的神经退化性疾病的血液生物标志。 Fujirebio and Eisai have agreed to collaborate on research and development of blood-based biomarkers for diagnosing neurodegenerative diseases, including Alzheimer's. 他们计划开发和商业化诸如p-Tau217等蛋白质诊断工具,并简化诊断方法。 They plan to develop and commercialize diagnostic tools for proteins like p-Tau217 and simplify diagnostic methods. 这一伙伴关系旨在增加全球获得新的诊断技术的机会,改善疾病诊断和治疗。 This partnership aims to enhance global access to new diagnostic technologies, improving disease diagnosis and treatment.